Short Interest in Aeterna Zentaris Inc. (NASDAQ:AEZS) Grows By 7.0%

Aeterna Zentaris Inc. (NASDAQ:AEZS – Get Rating) (TSE:AEZ) was the target of a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 87,000 shares, an increase of 7.0% from the February 13th total of 81,300 shares. Based on an average daily trading volume, of 15,700 shares, the short-interest ratio is presently 5.5 days. Currently, 1.8% of the company’s shares are sold short.

Aeterna Zentaris Price Performance

Shares of NASDAQ AEZS opened at $2.67 on Thursday. The company has a 50 day simple moving average of $3.50 and a 200 day simple moving average of $3.73. The firm has a market cap of $12.98 million, a PE ratio of -1.04 and a beta of 1.43. Aeterna Zentaris has a 1 year low of $2.54 and a 1 year high of $9.75.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of Aeterna Zentaris in a report on Saturday, March 11th. They set a “sell” rating for the company.

About Aeterna Zentaris

(Get Rating)

Æterna Zentaris, Inc operates as a specialty biopharmaceutical company, which engages in the development of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.